CTT Pharmaceutical CEO Ryan Khouri reports purchase of 2,100 shares worth $115.50

Reuters2026/08/25 01:03

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

CTT Pharmaceutical Holdings reported CEO Ryan Khouri bought 2,100 CTTH shares at $0.06 each.
Directly held stake rose to 9,360,756 shares following the purchase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CTT Pharmaceutical Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001035422-26-000007), on August 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

CTT Pharmaceutical CEO Ryan Khouri reports purchase of 2,100 shares worth $115.50

You may also like

Crypto prices